logo

For the Inventor, By the Inventor

Eagleville, PA, United States of America

Wei Zhao

This inventor holds 53 USPTO granted patents and 16 published patent applications and 20 EPO patents, primarily in ROR-Gamma Modulators (CPC class C07D). Top assignees: Vitae Pharmaceuticals, Inc., Inemsoft, Inc., Boehringer Ingelheim International Gmbh. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Zhao. Retrieved from https://idiyas.com/inventor/wei-zhao-oaua7a6b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 

% Patents Active = 67.9

 

Average Co-Inventor Count = 6.0

ph-index = 12

Forward Citations = 285(Granted Patents)

Forward Citations (Not Self Cited) = 182(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Eagleville, PA (US) (2010 - 2016)
  • Germantown, MD (US) (2001 - 2017)
  • San Mateo, CA (US) (2020)
  • North Potomac, MD (US) (2016 - 2022)
  • Allen, TX (US) (2016 - 2023)

Company Filing History:

goldMedal41 out of 85 
 
Vitae Pharmaceuticals, Inc.
 patents
silverMedal5 out of 5 
 
Inemsoft, Inc.
 patents
bronzeMedal3 out of 1,562 
 
Boehringer Ingelheim International Gmbh
 patents
4. 2 out of 1,334 
 
Hughes Electronics Corporation
 patents
5. 1 out of 797 
 
Hughes Network Systems, LLC
 patents
6. 4 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
ROR-Gamma Inhibitors
Communication Endpoints
LED Dimming
Substituted Indoles
Piperazine Derivatives
Liver X Receptor
Dihydropyrrolopyridine
Cyclic Urea
Aspartic Protease
Thiazolopyrrolidine
Benzimidazole Derivatives
Piperidine Renin
53 patents (USPTO):Explore Patents
1. 12143881 - Systems and methods of managing communication endpoints (2024-11-12),
2. 11553386 - Systems and methods of managing communication endpoints (2023-01-10),
3. 11535614 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2022-12-27),
4. 11001583 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2021-05-11),
5. 10939342 - Systems and methods of managing communication endpoints (2021-03-02),
6. 10829481 - Benzimidazole derivatives as modulators of ROR-gamma (2020-11-10),
7. 10829448 - Substituted benzoimidazoles as modulators of ROR-γ (2020-11-10),
8. 10807980 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2020-10-20),
9. 10738418 - Methods for modification of aramid fibers (2020-08-11),
10. 10470260 - Lamp power supply with 0 percent flicker and 0 flicker index (2019-11-05),
11. 10399976 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2019-09-03),
12. 10301261 - Substituted indoles as modulators of ROR-gamma (2019-05-28),
13. 10144715 - Piperazine derivatives as liver X receptor modulators (2018-12-04),
14. 10087184 - Dihydropyrrolopyridine inhibitors of RORγ (2018-10-02),
15. 10047085 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2018-08-14),

Title: Inventor Wei Zhao: Revolutionizing Technology in Eagleville, PA

Introduction: Wei Zhao is a visionary inventor based in Eagleville, PA, known for his groundbreaking contributions to the field of technology.

Latest Patents: Wei Zhao holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Wei Zhao has worked for leading tech companies, where he spearheaded projects that have led to significant advancements in various industries.

Collaborations: Wei Zhao has collaborated with top researchers, engineers, and scientists globally, fostering a culture of innovation and knowledge-sharing in his quest to push the boundaries of technology.

Conclusion: Wei Zhao's relentless pursuit of innovation and his passion for creating solutions to complex challenges make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…